Dose-finding study of NBX-100 in healthy adults
This trial tests a new investigational drug called NBX-100 in healthy volunteers to find the safest and most effective dose. It's for people who have had ayahuasca experiences before, to see if the drug is safe and how it affects the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 50 years old.
- You have had at least 2 ayahuasca experiences in the last 5 years, but not within the last month.
- You are generally healthy and not taking certain prescription or over-the-counter medications.
- You are willing to practice effective contraception if you or your partner could become pregnant.
- You have a person to pick you up and drive you home after each dose.
- You can tolerate blood draws and have good veins for IV access.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called AZD3974 in healthy people to see if it is safe and how the body handles it. It may help find the right dose for future studies.
This study tests an experimental drug called NS-079 in healthy people to see how safe it is and how the body processes it. It may help researchers learn if the drug could be used for future treatments.
This trial tests a single dose of a new medication (NM-101) in healthy male volunteers to see how the body handles it and if it's safe. It is a phase 1 study that requires you to be in good health and have no major medical conditions.
This study tests a new medicine called BLX-7006 in healthy adults to see if it is safe and to learn how the body handles it. Participating could help decide if the drug should be tested in people with certain conditions later.
This trial tests a new medicine called ADX-001 in healthy adults to see if it is safe, how the body handles it, and whether it triggers an immune response. It is an early-stage study, so it will help determine if the drug is safe enough for further testing in people with certain conditions.
This trial tests a new medicine called BCD-261 in healthy men to see if it is safe and how the body processes it. Participants will receive increasing doses and be monitored for about 4 months.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.